Terry Ramadhani, the CEO of the Kenya Medical Supplies Authority (KEMSA), has informed pharmaceutical, nursing, and medical stakeholders that the Authority’s reforms have begun in earnest.
KEMSA would be repositioned as an effective health products and technologies (HPTs) supply chain solutions provider in the local public healthcare market, according to the changes, she said.
Ms Ramadhani said the Authority is counting on the support of its stakeholders and will maintain a consultative approach in its operating model when she received a delegation from the Pharmaceutical Society of Kenya (PSK), Kenya Medical Association (KMA), Kenya Dentists Association, and the National Nurses Association of Kenya (NNA-Kenya).
PSK Chairperson Dr Louis Machogu, PSK CEO Dr Daniella Munene, KMA President Dr Were Onyino, NNA-Kenya National 2nd Vice Chairperson Mr Dennis Ngao Mbithi, and KDA President Dr Tim Theuri were among the delegation that paid the KEMSA CEO a courtesy call.
Ms Ramadhani shared her three-pronged approach following her recent appointment, which will focus on operational excellence, excellent customer experience, and organizational realignment to satisfy stakeholder objectives.
The Authority successfully reduced its order turnaround time (TAT) from 46 days in February 2021 to 14 days by the end of April 2022, demonstrating the effectiveness of its changes.
As part of a stakeholder engagement-focused credit management approach, the Authority is on track to collect more than Kshs 2.7 billion owing by County governments.
To improve its service delivery capabilities, the Authority has set a goal of collecting at least Kshs 500 million in unpaid dues from county governments each month under the new KEMSA Credit management plan.
